Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV001802673 | SCV002049635 | uncertain significance | Fibrosis of extraocular muscles, congenital, 5 | 2021-09-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002541371 | SCV003687784 | uncertain significance | Inborn genetic diseases | 2024-04-29 | criteria provided, single submitter | clinical testing | The c.130G>A (p.V44M) alteration is located in exon 2 (coding exon 1) of the COL25A1 gene. This alteration results from a G to A substitution at nucleotide position 130, causing the valine (V) at amino acid position 44 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |